You are here

  • Home
  • Archive
  • Volume 1, Issue 1
  • A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma

Article metrics

Article menu

Download PDFPDF

Research Article
A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma
Free

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019330
Jan 2020551
Feb 2020553
Mar 2020440
Apr 202013131
May 202018180
Jun 202012129
Jul 2020773
Aug 2020666
Sep 202020202
Oct 2020991
Nov 2020441
Dec 2020880
Jan 2021551
Feb 2021223
Mar 2021440
Apr 2021440
May 2021651
Jun 2021880
Jul 202110104
Aug 2021442
Sep 202112128
Oct 202117172
Nov 2021993
Dec 202110104
Jan 202215183
Feb 2022694
Mar 202220205
Apr 202214153
May 202224262
Jun 202226274
Jul 202219190
Aug 202232322
Sep 2022303018
Oct 202225263
Nov 202214143
Dec 202211113
Jan 202314146
Feb 202312124
Mar 2023202212
Apr 2023445
May 2023775
Jun 202312123
Jul 2023884
Aug 202311114
Sep 2023552
Oct 202325257
Nov 202336361
Dec 20231801803
Jan 2024141539
Feb 2024773
Mar 2024121254
Total808821257